People with leukemia are prone to a range of skin-related problems, from rashes and bruising to infections and bleeding into ...

A new strategy to strengthen the body’s natural immune defenses against cancer is showing early promise, particularly for patients with limited treatment options.

In a new study presented at the American Association for Cancer Research (AACR) Annual Meeting and published in Blood Cancer Discovery, titled, “Single-cell Transcriptional Atlas of Human ...

It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer, due to new research ...

How could relapse in leukemia after CAR T treatment—a problem that still affects between 30–60% of patients—be prevented? One major driver is antigen escape: leukemia cells can dial down or lose the ...

Dr. Dima El-Sharkawi discusses how hairy cell leukemia typically presents in patients and the challenges clinicians face in identifying the disease early. At the Hairy Cell Leukemia Foundation 2025 ...

A cord blood transplant combined with a pooled stem cell product showed a 96% one-year survival rate in leukemia patients, ...

An expert discusses IL-18-armored CAR T cells for adults with relapsed B-cell leukemia, showing complete remissions with manageable side effects. In an onsite interview with CURE at the 2025 ASH ...

Three clinically available drugs could pave the way for safer and more effective treatments for one of the most aggressive ...